Four-week safety and efficacy study of dorzolamide, a novel, active topical carbonic anhydrase inhibitor.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  A M A Archives of Ophthalmology

• Publication date

  1993-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/ARCHOPHT.1993.01090100051026PMID 8216014
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sezolamide: Additivity to timolol twice daily

  1992cited by this paper
• Six Week Safety Study of 2% MK-927 Administered Twice Daily to Ocular Hypertensive Volunteers

  1992cited by this paper
• Dose response and duration of action of dorzolamide, a topical carbonic anhydrase inhibitor.

  1992cited by this paper
• Multiple-dose, dose-response relationship for the topical carbonic anhydrase inhibitor MK-927.

  1991cited by this paper
• MK-507 (L-671 152) : lokale Verträglichkeit und Wirksamkeit eines neuen lokalen Karboanhydrasehemmers bei gesunden Probanden

  1991cited by this paper
• Multiple-dose efficacy comparison of the two topical carbonic anhydrase inhibitors sezolamide and MK-927.

  1991cited by this paper
• MK-507 (L-671,152), a topically active carbonic anhydrase inhibitor, reduces aqueous humor production in monkeys.

  1991cited by this paper
• Absence of metabolic effects of the topical carbonic anhydrase inhibitors MK‐927 and sezolamide during two‐week ocular administration to normal subjects

  1991cited by this paper
• Comparative tolerability of topical carbonic anhydrase inhibitor MK-927 and its S-enantiomer MK-417

  1991cited by this paper
• MK-507 versus sezolamide. Comparative efficacy of two topically active carbonic anhydrase inhibitors.

  1991cited by this paper
• MK-927: a topical carbonic anhydrase inhibitor. Dose response and duration of action.

  1990cited by this paper
• A single dose of the topical carbonic anhydrase inhibitor MK-927 decreases IOP in patients.

  1990cited by this paper
• [A new topical carbonic anhydrase inhibitor (MK-927). Tolerance comparison with betaxolol in healthy probands].

  1990cited by this paper
• MK-927: A Topically Active Ocular Hypotensive Carbonic Anhydrase Inhibitor

  1990cited by this paper
• Effects of ambient bicarbonate, phosphate and carbonic anhydrase inhibitors on fluid transport across rabbit corneal endothelium.

  1990cited by this paper
• The effect of MK-927, a topical carbonic anhydrase inhibitor, on IOP in glaucomatous monkeys.

  1990cited by this paper
• MK-927, a topical carbonic anhydrase inhibitor. Dose response and reproducibility.

  1990cited by this paper
• Chemical and pharmacological properties of MK-927, a sulfonamide carbonic anhydrase inhibitor that lowers intraocular pressure by the topical route.

  1990cited by this paper
• A comparison of L-671,152 and MK-927, two topically effective ocular hypotensive carbonic anhydrase inhibitors, in experimental animals.

  1990cited by this paper
• The ocular hypotensive effect of the topical carbonic anhydrase inhibitor L-671,152 in glaucomatous monkeys.

  1990cited by this paper
• MK-927: a topically effective carbonic anhydrase inhibitor in patients.

  1989cited by this paper
• Factors associated with visual outcome after photocoagulation for diabetic retinopathy. Diabetic Retinopathy Study Report #13.

  1989cited by this paper
• Local tolerance and activity of MK-927, a novel topical carbonic anhydrase inhibitor.

  1988cited by this paper
• Thienothiopyran-2-sulfonamides: a novel class of water-soluble carbonic anhydrase inhibitors.

  1987cited by this paper
• Carbonic anhydrase: General perspective and advances in glaucoma research

  1987cited by this paper
• Carbonic anhydrase II deficiency: diagnosis and carrier detection using differential enzyme inhibition and inactivation.

  1986cited by this paper
• Carbonic anhydrase isoenzymes CA I and CA II in the human eye.

  1986cited by this paper
• Topical carbonic anhydrase inhibitors.

  1984cited by this paper
• The relation between enzyme inhibition and physiological response in the carbonic anhydrase system.

  1963cited by this paper
• Nature of the inhibition of carbonic anhydrase by acetazolamide and benzthiazide.

  1961cited by this paper

• A Review of Ocular and Systemic Side Effects in Glaucoma Pharmacotherapy

  2025cites this paper
• Decoding Corneal Endothelial Loss from Glaucoma Treatment: A Case-Control Stratification Analysis

  2025cites this paper
• Regulation of ophthalmic ocular hypotensive drug approval in the US over the past 140 years.

  2024cites this paper
• The Multifarious Effects of Various Glaucoma Pharmacotherapy on Corneal Endothelium: A Narrative Review

  2023influential citation
• Screening for Glaucoma in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.

  2022cites this paper
• Carbonic Anhydrase Inhibitors in Ophthalmology: Glaucoma and Macular Oedema

  2021cites this paper
• Topical carbonic anhydrase inhibitors and glaucoma in 2021: where do we stand?

  2021cites this paper
• Omidenepag Isopropyl Versus Latanoprost in Primary Open-angle Glaucoma and Ocular Hypertension: ThePhase 3 AYAME Study.

  2020cites this paper
• Pharmacologie des médications antiglaucomateuses

  2020cites this paper
• Medical Management of Glaucoma

  2020cites this paper
• Effects of 2% Dorzolamide Hydrochloride and 0.005% Latanoprost Solutions on the Eye Surface of Rabbits

  2020cites this paper
• Pharmacokinetics, Safety, and Intraocular Pressure-Lowering Profile of Omidenepag Isopropyl, a Selective, Nonprostaglandin, Prostanoid EP2 Receptor Agonist, in Healthy Japanese and Caucasian Volunteers (Phase I Study)

  2019cites this paper
• The thick and thin of the central corneal thickness in glaucoma

  2018cites this paper
• A Prospective Comparative Study of Efficacy of Topical Anti – Glaucoma Drugs in Primary Open Angle Glaucoma

  2017cites this paper
• Erratum to : 24h Efficacy of Glaucoma Treatment Options KONSTAS

  2017cites this paper
• 24-h Efficacy of Glaucoma Treatment Options

  2016cites this paper
• Network Meta-analysis for Clinical Practice Guidelines: A Case Study on First-Line Medical Therapies for Primary Open-Angle Glaucoma

  2016cites this paper
• Short-Term Effect of Topical Brinzolamide 1%–Timolol 0.5% Fixed Combination on Human Central Corneal Thickness

  2015cites this paper
• Twenty-four hour efficacy of glaucoma medications.

  2015cites this paper
• Effect of topical prostaglandin analogues on corneal hysteresis

  2015influential citation
• The Placebo Effect in Early-Phase Glaucoma Clinical Trials

  2015cites this paper
• 67 – When to Perform Glaucoma Surgery

  2015cites this paper
• A COMPARATIVE STUDY OF THE EFFICACY AND ADVERSE EVENT PROFILE OF TOPICAL BRINZOLAMIDE WITH TOPICAL DORZOLAMIDE MONOTHERAPY IN PATIENTS OF PRIMARY OPEN ANGLE GLAUCOMA AND OCULAR HYPERTENSION IN A NORTH-INDIAN POPULATION

  2014cites this paper
• γ-Cyclodextrin Nanoparticle Eye Drops with Dorzolamide: Effect on Intraocular Pressure in Man

  2014cites this paper
• Intraocular pressure efficacy of glaucoma medications versus placebo in phase II compared to later phase trials

  2012cites this paper
• Effect of dorzolamide compared with timolol maleate on the central corneal thickness and endothelial-cell count of glaucomatous eyes

  2012cites this paper
• Diurnal and nocturnal variations in aqueous humor dynamics of patients with ocular hypertension undergoing medical therapy.

  2012cites this paper
• ESTUDIO DE VARIOS FÁRMACOS ANTIGLAUCOMATOSOS SOBRE DIVERSOS ASPECTOS MORFOLÓGICOS Y FUNCIONALES DEL SEGMENTO ANTERIOR

  2011cites this paper
• Aqueous humor flow rate in normal cats and the effect of topical 2% dorzolamide on aqueous humor flow and intraocular pressure

  2011cites this paper
• Production and Flow of Aqueous Humor

  2011cites this paper
• Mixed treatment comparison of repeated measurements of a continuous endpoint: an example using topical treatments for primary open‐angle glaucoma and ocular hypertension

  2011cites this paper
• The effect of dorzolamide 2% on circadian intraocular pressure in cats with primary congenital glaucoma.

  2011cites this paper
• Efficacy, safety and tolerability of combination therapy with timolol and dorzolamide in glaucoma and ocular hypertension

  2010cites this paper
• Efficacy, safety and tolerability of combination therapy with timolol and dorzolamide in glaucoma and ocular hypertension

  2010cites this paper
• Effects of topical dorzolamide on retinal and retrobulbar hemodynamics

  2009cites this paper
• CHAPTER 26 – Carbonic anhydrase inhibitors

  2009cites this paper
• Short-Term Effect of Topical Dorzolamide Hydrochloride on Intrastromal Corneal Pressure in Rabbit Corneas In Vivo

  2009cites this paper
• 2% dorzolamide and cornea: an ultrabiomicroscopic study.

  2009cites this paper
• Hypotensive effects of dorzolamide eyewash in maximal therapy glaucoma patients: a comparative study with oral acetazolamide.

  2009cites this paper
• Ocular hypotensive effect of ketanserin in patients with primary open angle glaucoma.

  2009cites this paper
• Role of carbonic anhydrase IV in corneal endothelial HCO3- transport.

  2008cites this paper
• Short-Term Effect of Topical Brinzolamide on Human Central Corneal Thickness

  2008cites this paper
• Effects of topical administration of 1% brinzolamide on intraocular pressure in clinically normal horses.

  2008cites this paper
• Effects of antiglaucoma drugs on refractive outcomes in eyes with myopic regression after laser in situ keratomileusis.

  2008cites this paper
• Effect of dorzolamide hydrochloride on central corneal thickness in humans with cornea guttata.

  2007cites this paper
• Central corneal thickness in the European Glaucoma Prevention Study.

  2007cites this paper
• Comparing the fixed combination brimonidine-timolol versus fixed combination dorzolamide-timolol in patients with elevated intraocular pressure*

  2007cites this paper
• Frequency Doubling Perimetry

  2006cites this paper
• Terapia combinada con timolol/dorzolamida versus timolol/pilocarpina en el glaucoma primario de ángulo abierto

  2006cites this paper
• Effect of topical dorzolamide on rabbit central corneal thickness.

  2006cites this paper
• Hornhaut-Pachymetrie und Augeninnendruck

  2005cites this paper
• Corneal thickness and daily curve of intraocular pressure in suspected and glaucomatous patients.

  2005cites this paper
• Medical therapy of glaucoma.

  2005cites this paper
• Central corneal thickness: will one measurement suffice?

  2005cites this paper
• Central corneal thickness and glaucoma in aphakic and pseudophakic children.

  2005cites this paper
• [Corneal pachymetry and intraocular pressure].

  2005cites this paper
• Water-Drinking Test in Patients with Primary Open-Angle Glaucoma While Treated with Different Topical Medications

  2005cites this paper
• Feline glaucomas.

  2005cites this paper
• EFEITOS DO CLORIDRATO DE DORZOLAMIDA 2%, MALEATO DE TIMOLOL 0,5% E ASSOCIAÇÃO NA PRESSÃO INTRA-OCULAR. ESTUDO EXPERIMENTAL EM CÃES.

  2004cites this paper
• Ocular hypotensive effect and safety of brinzolamide ophthalmic solution in open angle glaucoma patients.

  2004cites this paper
• Clinical responses of the corneal endothelium.

  2004cites this paper
• Short-term ocular tolerability of dorzolamide 2% and brinzolamide 1% vs placebo in primary open-angle glaucoma and ocular hypertension subjects

  2004cites this paper
• Additive effect of latanoprost and dorzolamide in patients with elevated intraocular pressure

  2004cites this paper
• Whole-blood pharmacokinetics and metabolic effects of the topical carbonic anhydrase inhibitor dorzolamide

  2004cites this paper
• Comparison of Latanoprost and Dorzolamide in Patients with Open Angle Glaucoma

  2003cites this paper
• Ocular Factors Relevant to Anti-Glaucomatous Eyedrop-Related Keratoepitheliopathy

  2003cites this paper
• Timolol 0.5%/dorzolamide 2% fixed combination versus timolol 0.5%/pilocarpine 2% fixed combination in primary open-angle glaucoma or ocular hypertensive patients.

  2003cites this paper
• Effects of topical administration of 1% brinzolamide on normal cat eyes.

  2003cites this paper
• Brimonidine purite 0.15% versus dorzolamide 2% each given twice daily to reduce intraocular pressure in subjects with open angle glaucoma or ocular hypertension

  2003cites this paper
• Prise en charge d’un hyphéma post-traumatique

  2003cites this paper
• Influence of dorzolamide on corneal endothelium.

  2003cites this paper
• Acute and Chronic Ocular Symptoms of Dorzolamide 2% Compared with Placebo

  2003cites this paper
• Blindness in patients with treated open-angle glaucoma.

  2003cites this paper
• Short-term effect of dorzolamide hydrochloride on central corneal thickness in humans with cornea guttata.

  2003cites this paper
• What Type of Pivotal Study Design is Appropriate for an Investigational New Drug to Manage Chronic Angle Closure Glaucoma: Active Control or Placebo?

  2002cites this paper
• Clinical Pharmacokinetics of Dorzolamide

  2002cites this paper
• Dorzolamide x Apraclonidine in the prevention of the intraocular pressure spike after Nd : YAG laser posterior capsulotomy

  2002cites this paper
• Inhibition of carbonic anhydrase activity in cultured bovine corneal endothelial cells by dorzolamide.

  2002cites this paper
• Periorbital dermatitis as a side effect of topical dorzolamide

  2002cites this paper
• Advances in topical glaucoma therapy.

  2002cites this paper
• Tolerability and Efficacy of Dorzolamide Versus Acetazolamide added to Timolol

  2002cites this paper
• Dorzolamide and ocular blood flow in previously untreated glaucoma patients: a controlled double-masked study.

  2002cites this paper
• Management of traumatic hyphema.

  2002cites this paper
• Refractive Change after Dorzolamide Use in Patients with Primary Open-Angle Glaucoma and Ocular Hypertension

  2001cites this paper
• Efficacy of brimonidine 0.2% and dorzolamide 2% as adjunctive therapy to beta-blockers in adult patients with glaucoma or ocular hypertension.

  2001cites this paper
• Effect of topical administration of 2% dorzlamide hydrochloride or 2% dorzlamide hydrochloride-0.5% timolol maleate on intraocular pressure in clinically normal horses.

  2001cites this paper
• Update on topical carbonic anhydrase inhibitors

  2001cites this paper
• Effects of topical application of a 2% solution of dorzolamide on intraocular pressure and aqueous humor flow rate in clinically normal dogs.

  2001cites this paper
• Comparisons of Intraocular-Pressure- Lowering Efficacy and Side Effects of 2% Dorzolamide and 1% Brinzolamide

  2001cites this paper
• Inhibition of Carbonic Anhydrase in the Lens does not Induce Myopia in Cynomolgus Monkeys

  2001cites this paper
• Comparison of the Additive Intraocular Pressure–Lowering Effect of Latanoprost and Dorzolamide When Added to Timolol in Patients With Open-angle Glaucoma or Ocular Hypertension: A Randomized, Open-label, Multicenter Study in Greece

  2001cites this paper
• A comparison of latanoprost and dorzolamide in patients with glaucoma and ocular hypertension: a 3 month, randomised study

  2000cites this paper
• Maksimal Medikal Tedavili Glokom Olgularında%2'lik Dorzolamid Kullanımının Uzun Dönem Sonuçları

  2000cites this paper
• Carbonic anhydrase inhibition in ophthalmology: carbonic anhydrases in cornea, lens, retina and lacrimal gland.

  2000cites this paper
• The design of new carbonic anhydrase inhibitors.

  2000cites this paper
• Pharmacological and ocular hypotensive properties of topical carbonic anhydrase inhibitors.

  2000cites this paper
• Topical Dorzolamide 2%/Timolol 0.5%

  2000cites this paper
• Twenty-four hour control of intraocular pressure with dorzolamide and timolol maleate in exfoliation and primary open-angle glaucoma

  2000cites this paper
• Randomised fellow eye comparison of the effectiveness of dorzolamide and apraclonidine on intraocular pressure following phacoemulsification cataract surgery

  2000cites this paper
• Human corneal thickness and its impact on intraocular pressure measures: a review and meta-analysis approach.

  2000cites this paper